SlideShare a Scribd company logo
Presented By…..
Mr. Tarif Hussian
M.Pharm. (SEM-I)
Dept. of Pharmaceutical Sciences
Guided By…..
DR. Arun Nanda
Professor of Pharmaceutics
2
Contents
● Introduction
● History
● Organization of FDA
The Center for Biologics Evaluation and Research (CBER)
The Center for Devices and Radiological Health (CDRH)
The Center for Drug Evaluation and Research (CDER)
The Center for Food Safety and Applied Nutrition (CFSAN)
Center for Tobacco Products
The Center for Veterinary Medicine (CVM)
The National Center for Toxicological Research (NCTR)
● Conclusion
c
3
INTRODUCTION
The Food and Drug Administration (1930) is a federal agency of
the United States Department of Health and Human Services, one of
the United States federal executive departments.
 Its headquarter located at White Oak, Maryland
The agency also has 223 field offices and13 laboratories located throughout the 50
states of USA.
Mission is to protecting consumers and promote public health .
FDA started opening office in foreign countries including China ,India, Costa Rica ,
Chile, Belgium and UK etc.
What does FDA regulate?
Foods, except for most meat and poultry products, which are regulated by the
U.S. Department of Agriculture.
Food additives
Infant formulas
Dietary supplements
Human drugs
Vaccines, blood products, and other biologics
Medical devices, from simple items like tongue depressors, to complex
technologies such as heart pacemakers.
Electronic products that give off radiation, such as microwave ovens and X-ray
equipment.
Cosmetics.
Feed, drugs, and devices used in pets, farm animals, and other animals.
Tobacco products
5
FDA does not regulate
Advertising (except for prescription drugs, medical devices, and tobacco
products)
 Alcoholic beverages
Some consumer products, such as paint, child- resistant packages, baby toys,
and household appliances (except for those that give off radiation)
 Illegal drugs of abuse, such as heroin and marijuana.
 Health insurance
 Meat and poultry (except for game meats, such as venison, ostrich, and snake).
 Restaurants and grocery stores.
What doesn’t FDA regulate ?
1902 – Biologics Control Act
1906 – Pure Food and Drug Act
1944 – Public Health Service Act
1951 – Food, Drug, and Cosmetics Act Amendments
1962 – Food, Drug, and Cosmetics Act Amendments
1966 – Fair Packaging and Labeling Act
1976 – Medical Device Regulation Act
1987 – Prescription Drug Marketing Act
1988 – Anti–drug Abuse Act
1990 – Nutrition Labeling and Education Act
1992 – Prescription Drug User Fee Act
1994 – Dietary Supplement Health and Education Act
1997 – Food and Drug Modernization Act
2002 – Bioterrorism Act
2002 – Medical Device User Fee and Modernization Act (MDUFMA)
2003 – Animal Drug User Fee Act
2007 – Food and Drug Administration Amendments Act of 2007
Note:-The FDA also enforces other laws, notably Section 361 of the Public Health Service Act
and associated regulations, many of which are not directly related to food or drugs.
HISTORY
7
ORGANIZATION OF FDA
● FDA Commissioner :- Dr. Stephen M. Hahn
● The Office of Regulatory Affairs (ORA):- which conducts inspections
and enforces FDA regulations.
● The Center for Biologics Evaluation and Research (CBER):- which regulates products
such as vaccines, blood, and gene therapy.
● The Center for Devices and Radiological Health (CDRH):- Which regulates medical
devices ranging from thermometers to kidney dialysis machines, and electronic products that
give off radiation, such as microwave ovens.
● The Center for Drug Evaluation and Research (CDER):-which regulates over-the-counter
and prescription medications.
● The Center for Food Safety and Applied Nutrition (CFSAN):- which regulates most foods
(except meat and poultry, which are regulated by the U.S. Department of Agriculture).
● Center for Tobacco Products:- which regulates cigarettes, cigarette tobacco, roll-your-own
tobacco, and smokeless tobacco.
● The Center for Veterinary Medicine (CVM):- which regulates feed and drugs and devices
used in pets, farm animals, and other animals.
● The National Center for Toxicological Research (NCTR):- which supports FDA’s product
centers by providing innovative scientific technology, training, and technical expertise.
FDA ADVISORY COMMITTEE
8
Advisory committees provide FDA with independent advice from outside
experts on issues related to human and veterinary drugs, vaccines and
other biological products, medical devices, and food.
In general, advisory committees include a chair, several members, plus
a consumer, industry, and sometimes a patient representative.
Additional experts with special knowledge may be added for individual
committee meetings as needed.
Although the committees provide advice to the agency, FDA makes the
final decisions.
The Center for Biologics Evaluation
and
Research (CBER)
9
Biologic – a compound consisting or derived from, all or part of a living organism and used for
therapeutic or diagnostic purposes.
Examples of biological products include
● Vaccines blood and blood products ● Allergenic extracts
● Human cells and tissues used for transplantation (e.g. tendons, ligaments and bone)
● Gene therapies ● Cellular therapies
● Tests to screen potential blood donors for infectious agents such as HIV
Biologics License Applications (BLA) Process (CBER)
The Biologics License Application (BLA) is a request for permission to introduce, or deliver for
introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is
regulated under 21 CFR 600 – 680. Form 356h specifies the requirements for a BLA. This
includes:
Applicant information
Product/Manufacturing information
Pre-clinical studies
Clinical studies
Labeling
10
BLA Submission
After 60 days
If application
filable
Approved
Refused
If safe and
effective for its
labeled indication
● CBER controls the regulatory oversight of biologics INDs.
● BLA submission and Review-
11
Center for Devices and Radiological Health
(CDRH)
● Premarket approval of all medical devices
● Medical device includes products from the simple toothbrush to complex
devices such as implantable brain pacemakers
● Also oversees the safety performance of non-medical devices which emit
certain types of electromagnetic radiation
● Regulates following category of radiation emitting electronic products:-
Radiation
• Ionizing X-ray:- e.g. Dental radiography, Industrial X-ray etc.
• Optical (Visible, UV, IR, Laser):-e.g. Surgical laser, Germicide lamp etc.
• RF, Microwave, magnetic: - e.g. MRI, Microwave oven etc.
• Acoustic (Ultrasonic):- e.g. Ultrasonography, Hearing aids etc.
12
Functions of CDRH- Benefits Risks Regulate firms who
manufacture , repackage , relabel or Import medical devices sold in US .
● Getting safe and effective devices to market as quickly as possible
while ensuring that devices currently on the market remain safe and
effective .
● minimizes human exposure to radiation from medical, occupational and
consumer products.
● Providing accurate, science-based information about the products.
● Prescribes and enforces GMPs and performance standards for radiation-
emitting electronic products and medical devices
● To recall defective or noncompliant products.
13
Class I (General Controls) –
• are low risk product
• e.g.- manual surgical instruments, canes, patient scales, adhesive bandages etc.
• Manufacturers have to register their facilities, list the products they manufacture, and
comply with GMPs.
• are exempt from 510(k) pre-market clearance application submission.
Class II (Special Controls) –
• entail a moderate degree of risk
• e.g. ECG monitors, x-ray machines and endoscopes
• Have to produce adequate assurance of safety and effectiveness
• require submission of a 510(k) premarket notification to FDA
Class III (Premarket Approval) –
• entail significant risk to the patient
• e.g. implantable cardiac pacemakers, angioplasty catheters
• manufacturer must submit to the FDA a Premarket approval application (PMA )
Classification of medical devices according to
M.D. Amendments; 1976:
Center for Drug Evaluation and Research
(CDER)
● Acts as consumer watchdog in America’s healthcare system.
● Oversees the research, development, manufacture and marketing of
drugs.
● Ensures safety and efficacy of available drugs.
● regulates :
● Prescription drugs
● Generic drugs
● OTC drugs
● Also ensures truth in advertising for prescription drugs.
14
15
The Center for Food Safety and Applied Nutrition
(CFSAN) Regulates –
 food (except meat, poultry)
 Dietary supplements
 Bottled water and
 cosmetic products.
 The Food Safety Inspection Service (FSIS) in the U.S. Department of Agriculture
regulates meat and poultry products .
 Ensures that food products are safe, sanitary, wholesome and honestly labeled.
Dietary supplements
 The Dietary Supplement Health and Education Act (DSHEA) of 1994, created a new
regulatory framework for the safety and labeling of dietary supplements.
 A dietary supplement is a product taken by mouth that contains a "dietary ingredient" intended to
supplement the diet.
 A Dietary ingredient must be one or any combination of the following substances:
● a vitamin ● a mineral ● herb or other botanical ● an amino acid ● a dietary substance for
use by man to supplement the diet by increasing the total dietary intake (e.g., enzymes or tissues
from organs or glands) ● a concentrate, metabolite, constituent or extract.
16
 Under the Federal Food, Drug, and Cosmetic Act (FFDCA) they do
not require FDA approval before they go on the market(except- colour
additives)
 FDA can only act after a cosmetic is on the market
 The agency has ways to monitor these products, which are-
• Voluntary Cosmetic Registration Program(VCRP)
• Inspections
• Surveys of products
• Cosmetic Ingredient Review (CIR) expert panel
 Also regulates labeling of cosmetics
Cosmetics Regulation
17
 It Came into force after Family Smoking Prevention and Tobacco
Control Act,2009
 Authorizes FDA to-
• Require disclosure of tobacco product ingredients
• Create standards for tobacco products
• Restrict tobacco sales, distribution and marketing
• Require stronger health warning on packaging and in advertising
 Restricts the access and attractiveness of cigarettes to kids
 Bans the manufacture or sale of fruit or candy flavored cigarettes
 Convenes the Center’s Tobacco Products Scientific Advisory Committee for
use of menthol in cigarettes, dissolvable tobacco products
 Produces public information and education campaigns
Center For Tobacco Products
• Regulates food, food additives, and drugs that are given to animals(food animals, pets)
Primary focus –
1.on medications that are used in food animals.
2. assurance that they don’t affect human food supply
• Restricts the spread of bovine spongiform encephalopathy by doing inspections of
feed manufacturers
• New Animal Drug Application (NADA) submitted by sponsor
• Safety and efficacy of New Animal Drug Product should be assured before approval.
18
Center for Veterinary Sciences
(CVS)
• Research arm of FDA
• The research at NCTR supports FDA’s goals:
1) To understand critical biological events in the expression of toxicity,.
2) To develop and characterize methods, and incorporate new technologies
to improve the assessment of human exposure, susceptibility, and risk.
3) To increase the understanding of the interaction between genetics,
metabolism, and nutrition.
19
National Center for toxicological Research
(NCTR)
20
Calm mind brings
inner strength and
self-confidence, so
that's very
important for good
Health.
Dalai Lama
21

More Related Content

What's hot

US FDA
US FDA US FDA
US FDA
Suvarta Maru
 
NDA Application.pptx
NDA Application.pptxNDA Application.pptx
NDA Application.pptx
Venugopal N
 
USFDA
USFDAUSFDA
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
Arpitha Aarushi
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Drug regulatory authority
Drug regulatory authority Drug regulatory authority
Drug regulatory authority
Rahul Gawande
 
Marketing Authorization Procedure in European Union
Marketing Authorization Procedure in European UnionMarketing Authorization Procedure in European Union
Marketing Authorization Procedure in European Union
Doninder Hooda
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
Manish kumar
 
NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)
Navalika Polishetty
 
Who prequalification program
Who prequalification programWho prequalification program
Who prequalification program
shweta more
 
European medicines agency
European medicines agencyEuropean medicines agency
European medicines agency
Vicky Vignesh
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
Vikas Rathee
 
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptxBasics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
JAYA PRAKASH VELUCHURI
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
Swapnil Fernandes
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
PrachiSharma575050
 
U.S. Regulation of Biosimilars
U.S. Regulation of BiosimilarsU.S. Regulation of Biosimilars
U.S. Regulation of Biosimilars
Michael Swit
 
GOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEGOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICE
jagrutivasava
 
Doc in pharma
Doc in pharmaDoc in pharma
Doc in pharma
maitreyi zaveri
 

What's hot (20)

US FDA
US FDA US FDA
US FDA
 
NDA Application.pptx
NDA Application.pptxNDA Application.pptx
NDA Application.pptx
 
USFDA
USFDAUSFDA
USFDA
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
Drug regulatory authority
Drug regulatory authority Drug regulatory authority
Drug regulatory authority
 
Marketing Authorization Procedure in European Union
Marketing Authorization Procedure in European UnionMarketing Authorization Procedure in European Union
Marketing Authorization Procedure in European Union
 
Hatch waxman act
Hatch waxman actHatch waxman act
Hatch waxman act
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)
 
Who prequalification program
Who prequalification programWho prequalification program
Who prequalification program
 
European medicines agency
European medicines agencyEuropean medicines agency
European medicines agency
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
 
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptxBasics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
 
U.S. Regulation of Biosimilars
U.S. Regulation of BiosimilarsU.S. Regulation of Biosimilars
U.S. Regulation of Biosimilars
 
GOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEGOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICE
 
ACTD Guidelines Overview
ACTD Guidelines OverviewACTD Guidelines Overview
ACTD Guidelines Overview
 
Doc in pharma
Doc in pharmaDoc in pharma
Doc in pharma
 

Similar to USFDA Over View

Usfda swatee
Usfda swateeUsfda swatee
Usfda swatee
Saket Singh
 
Usfda
Usfda Usfda
Usfda
Hemang Patel
 
Therapeutic Goods Administration
Therapeutic Goods Administration Therapeutic Goods Administration
Therapeutic Goods Administration
MAHARNABPRADHANVP21P
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
Raj Tiwari
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
Shaik Sana
 
Roshan (1)
Roshan (1)Roshan (1)
Roshan (1)
PranitaJirvankar
 
Usfda ppn
Usfda ppnUsfda ppn
FDA- SEMINAR.pptx
FDA- SEMINAR.pptxFDA- SEMINAR.pptx
FDA- SEMINAR.pptx
Vel Kumar
 
Food and Drugs Administration.pptx
Food and Drugs Administration.pptxFood and Drugs Administration.pptx
Food and Drugs Administration.pptx
Ankitsharma811886
 
Usfda
UsfdaUsfda
Madhu k s
Madhu k s Madhu k s
Madhu k s
Madhu Honey
 
Industry and fda laision &
Industry and fda laision &Industry and fda laision &
Industry and fda laision &
BhanuSriChandanaKnch
 
regulaotryauthorities-160426054815.pdf
regulaotryauthorities-160426054815.pdfregulaotryauthorities-160426054815.pdf
regulaotryauthorities-160426054815.pdf
Vhuii
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
Sagar Savale
 
Regulatory bodies & CRO
Regulatory bodies & CRORegulatory bodies & CRO
Regulatory bodies & CRO
Suraj Choudhary
 
THERAPEUTIC GOODS ADMINSTRATION
THERAPEUTIC GOODS ADMINSTRATIONTHERAPEUTIC GOODS ADMINSTRATION
MHRA.pptx
MHRA.pptxMHRA.pptx
MHRA.pptx
TariqHusain19
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Rajashri Survase Ojha
 

Similar to USFDA Over View (20)

Usfda swatee
Usfda swateeUsfda swatee
Usfda swatee
 
Usfda
Usfda Usfda
Usfda
 
Therapeutic Goods Administration
Therapeutic Goods Administration Therapeutic Goods Administration
Therapeutic Goods Administration
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
 
Roshan (1)
Roshan (1)Roshan (1)
Roshan (1)
 
Usfda ppn
Usfda ppnUsfda ppn
Usfda ppn
 
FDA- SEMINAR.pptx
FDA- SEMINAR.pptxFDA- SEMINAR.pptx
FDA- SEMINAR.pptx
 
Food and Drugs Administration.pptx
Food and Drugs Administration.pptxFood and Drugs Administration.pptx
Food and Drugs Administration.pptx
 
Usfda
UsfdaUsfda
Usfda
 
Madhu k s
Madhu k s Madhu k s
Madhu k s
 
Industry and fda laision &
Industry and fda laision &Industry and fda laision &
Industry and fda laision &
 
regulaotryauthorities-160426054815.pdf
regulaotryauthorities-160426054815.pdfregulaotryauthorities-160426054815.pdf
regulaotryauthorities-160426054815.pdf
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
 
Regulatory bodies & CRO
Regulatory bodies & CRORegulatory bodies & CRO
Regulatory bodies & CRO
 
THERAPEUTIC GOODS ADMINSTRATION
THERAPEUTIC GOODS ADMINSTRATIONTHERAPEUTIC GOODS ADMINSTRATION
THERAPEUTIC GOODS ADMINSTRATION
 
Agencies dhwani
Agencies dhwaniAgencies dhwani
Agencies dhwani
 
MHRA.pptx
MHRA.pptxMHRA.pptx
MHRA.pptx
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
 
Usfda sana 1
Usfda sana 1Usfda sana 1
Usfda sana 1
 

Recently uploaded

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 

Recently uploaded (20)

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 

USFDA Over View

  • 1. Presented By….. Mr. Tarif Hussian M.Pharm. (SEM-I) Dept. of Pharmaceutical Sciences Guided By….. DR. Arun Nanda Professor of Pharmaceutics
  • 2. 2 Contents ● Introduction ● History ● Organization of FDA The Center for Biologics Evaluation and Research (CBER) The Center for Devices and Radiological Health (CDRH) The Center for Drug Evaluation and Research (CDER) The Center for Food Safety and Applied Nutrition (CFSAN) Center for Tobacco Products The Center for Veterinary Medicine (CVM) The National Center for Toxicological Research (NCTR) ● Conclusion c
  • 3. 3 INTRODUCTION The Food and Drug Administration (1930) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.  Its headquarter located at White Oak, Maryland The agency also has 223 field offices and13 laboratories located throughout the 50 states of USA. Mission is to protecting consumers and promote public health . FDA started opening office in foreign countries including China ,India, Costa Rica , Chile, Belgium and UK etc.
  • 4. What does FDA regulate? Foods, except for most meat and poultry products, which are regulated by the U.S. Department of Agriculture. Food additives Infant formulas Dietary supplements Human drugs Vaccines, blood products, and other biologics Medical devices, from simple items like tongue depressors, to complex technologies such as heart pacemakers. Electronic products that give off radiation, such as microwave ovens and X-ray equipment. Cosmetics. Feed, drugs, and devices used in pets, farm animals, and other animals. Tobacco products
  • 5. 5 FDA does not regulate Advertising (except for prescription drugs, medical devices, and tobacco products)  Alcoholic beverages Some consumer products, such as paint, child- resistant packages, baby toys, and household appliances (except for those that give off radiation)  Illegal drugs of abuse, such as heroin and marijuana.  Health insurance  Meat and poultry (except for game meats, such as venison, ostrich, and snake).  Restaurants and grocery stores. What doesn’t FDA regulate ?
  • 6. 1902 – Biologics Control Act 1906 – Pure Food and Drug Act 1944 – Public Health Service Act 1951 – Food, Drug, and Cosmetics Act Amendments 1962 – Food, Drug, and Cosmetics Act Amendments 1966 – Fair Packaging and Labeling Act 1976 – Medical Device Regulation Act 1987 – Prescription Drug Marketing Act 1988 – Anti–drug Abuse Act 1990 – Nutrition Labeling and Education Act 1992 – Prescription Drug User Fee Act 1994 – Dietary Supplement Health and Education Act 1997 – Food and Drug Modernization Act 2002 – Bioterrorism Act 2002 – Medical Device User Fee and Modernization Act (MDUFMA) 2003 – Animal Drug User Fee Act 2007 – Food and Drug Administration Amendments Act of 2007 Note:-The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. HISTORY
  • 7. 7 ORGANIZATION OF FDA ● FDA Commissioner :- Dr. Stephen M. Hahn ● The Office of Regulatory Affairs (ORA):- which conducts inspections and enforces FDA regulations. ● The Center for Biologics Evaluation and Research (CBER):- which regulates products such as vaccines, blood, and gene therapy. ● The Center for Devices and Radiological Health (CDRH):- Which regulates medical devices ranging from thermometers to kidney dialysis machines, and electronic products that give off radiation, such as microwave ovens. ● The Center for Drug Evaluation and Research (CDER):-which regulates over-the-counter and prescription medications. ● The Center for Food Safety and Applied Nutrition (CFSAN):- which regulates most foods (except meat and poultry, which are regulated by the U.S. Department of Agriculture). ● Center for Tobacco Products:- which regulates cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. ● The Center for Veterinary Medicine (CVM):- which regulates feed and drugs and devices used in pets, farm animals, and other animals. ● The National Center for Toxicological Research (NCTR):- which supports FDA’s product centers by providing innovative scientific technology, training, and technical expertise.
  • 8. FDA ADVISORY COMMITTEE 8 Advisory committees provide FDA with independent advice from outside experts on issues related to human and veterinary drugs, vaccines and other biological products, medical devices, and food. In general, advisory committees include a chair, several members, plus a consumer, industry, and sometimes a patient representative. Additional experts with special knowledge may be added for individual committee meetings as needed. Although the committees provide advice to the agency, FDA makes the final decisions.
  • 9. The Center for Biologics Evaluation and Research (CBER) 9 Biologic – a compound consisting or derived from, all or part of a living organism and used for therapeutic or diagnostic purposes. Examples of biological products include ● Vaccines blood and blood products ● Allergenic extracts ● Human cells and tissues used for transplantation (e.g. tendons, ligaments and bone) ● Gene therapies ● Cellular therapies ● Tests to screen potential blood donors for infectious agents such as HIV Biologics License Applications (BLA) Process (CBER) The Biologics License Application (BLA) is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680. Form 356h specifies the requirements for a BLA. This includes: Applicant information Product/Manufacturing information Pre-clinical studies Clinical studies Labeling
  • 10. 10 BLA Submission After 60 days If application filable Approved Refused If safe and effective for its labeled indication ● CBER controls the regulatory oversight of biologics INDs. ● BLA submission and Review-
  • 11. 11 Center for Devices and Radiological Health (CDRH) ● Premarket approval of all medical devices ● Medical device includes products from the simple toothbrush to complex devices such as implantable brain pacemakers ● Also oversees the safety performance of non-medical devices which emit certain types of electromagnetic radiation ● Regulates following category of radiation emitting electronic products:- Radiation • Ionizing X-ray:- e.g. Dental radiography, Industrial X-ray etc. • Optical (Visible, UV, IR, Laser):-e.g. Surgical laser, Germicide lamp etc. • RF, Microwave, magnetic: - e.g. MRI, Microwave oven etc. • Acoustic (Ultrasonic):- e.g. Ultrasonography, Hearing aids etc.
  • 12. 12 Functions of CDRH- Benefits Risks Regulate firms who manufacture , repackage , relabel or Import medical devices sold in US . ● Getting safe and effective devices to market as quickly as possible while ensuring that devices currently on the market remain safe and effective . ● minimizes human exposure to radiation from medical, occupational and consumer products. ● Providing accurate, science-based information about the products. ● Prescribes and enforces GMPs and performance standards for radiation- emitting electronic products and medical devices ● To recall defective or noncompliant products.
  • 13. 13 Class I (General Controls) – • are low risk product • e.g.- manual surgical instruments, canes, patient scales, adhesive bandages etc. • Manufacturers have to register their facilities, list the products they manufacture, and comply with GMPs. • are exempt from 510(k) pre-market clearance application submission. Class II (Special Controls) – • entail a moderate degree of risk • e.g. ECG monitors, x-ray machines and endoscopes • Have to produce adequate assurance of safety and effectiveness • require submission of a 510(k) premarket notification to FDA Class III (Premarket Approval) – • entail significant risk to the patient • e.g. implantable cardiac pacemakers, angioplasty catheters • manufacturer must submit to the FDA a Premarket approval application (PMA ) Classification of medical devices according to M.D. Amendments; 1976:
  • 14. Center for Drug Evaluation and Research (CDER) ● Acts as consumer watchdog in America’s healthcare system. ● Oversees the research, development, manufacture and marketing of drugs. ● Ensures safety and efficacy of available drugs. ● regulates : ● Prescription drugs ● Generic drugs ● OTC drugs ● Also ensures truth in advertising for prescription drugs. 14
  • 15. 15 The Center for Food Safety and Applied Nutrition (CFSAN) Regulates –  food (except meat, poultry)  Dietary supplements  Bottled water and  cosmetic products.  The Food Safety Inspection Service (FSIS) in the U.S. Department of Agriculture regulates meat and poultry products .  Ensures that food products are safe, sanitary, wholesome and honestly labeled. Dietary supplements  The Dietary Supplement Health and Education Act (DSHEA) of 1994, created a new regulatory framework for the safety and labeling of dietary supplements.  A dietary supplement is a product taken by mouth that contains a "dietary ingredient" intended to supplement the diet.  A Dietary ingredient must be one or any combination of the following substances: ● a vitamin ● a mineral ● herb or other botanical ● an amino acid ● a dietary substance for use by man to supplement the diet by increasing the total dietary intake (e.g., enzymes or tissues from organs or glands) ● a concentrate, metabolite, constituent or extract.
  • 16. 16  Under the Federal Food, Drug, and Cosmetic Act (FFDCA) they do not require FDA approval before they go on the market(except- colour additives)  FDA can only act after a cosmetic is on the market  The agency has ways to monitor these products, which are- • Voluntary Cosmetic Registration Program(VCRP) • Inspections • Surveys of products • Cosmetic Ingredient Review (CIR) expert panel  Also regulates labeling of cosmetics Cosmetics Regulation
  • 17. 17  It Came into force after Family Smoking Prevention and Tobacco Control Act,2009  Authorizes FDA to- • Require disclosure of tobacco product ingredients • Create standards for tobacco products • Restrict tobacco sales, distribution and marketing • Require stronger health warning on packaging and in advertising  Restricts the access and attractiveness of cigarettes to kids  Bans the manufacture or sale of fruit or candy flavored cigarettes  Convenes the Center’s Tobacco Products Scientific Advisory Committee for use of menthol in cigarettes, dissolvable tobacco products  Produces public information and education campaigns Center For Tobacco Products
  • 18. • Regulates food, food additives, and drugs that are given to animals(food animals, pets) Primary focus – 1.on medications that are used in food animals. 2. assurance that they don’t affect human food supply • Restricts the spread of bovine spongiform encephalopathy by doing inspections of feed manufacturers • New Animal Drug Application (NADA) submitted by sponsor • Safety and efficacy of New Animal Drug Product should be assured before approval. 18 Center for Veterinary Sciences (CVS)
  • 19. • Research arm of FDA • The research at NCTR supports FDA’s goals: 1) To understand critical biological events in the expression of toxicity,. 2) To develop and characterize methods, and incorporate new technologies to improve the assessment of human exposure, susceptibility, and risk. 3) To increase the understanding of the interaction between genetics, metabolism, and nutrition. 19 National Center for toxicological Research (NCTR)
  • 20. 20
  • 21. Calm mind brings inner strength and self-confidence, so that's very important for good Health. Dalai Lama 21